mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
Doxorubicin |
FIMM |
pan-cancer |
AAC |
0.039 |
0.8 |
mRNA |
ETP-46464 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.8 |
mRNA |
shikonin |
GDSC1000 |
pan-cancer |
AAC |
0.0097 |
0.8 |
mRNA |
KU-55933 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
Salubrinal |
GDSC1000 |
pan-cancer |
AAC |
-0.014 |
0.8 |
mRNA |
ABT-263 |
FIMM |
pan-cancer |
AAC |
0.038 |
0.8 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0095 |
0.8 |